CSL Plasma, the plasma collection business of global biotherapeutics leader CSL Behring, today announced the opening of its 300th U.S. plasma center, which is located in Greenacres, Florida. CSL Plasma is one of the world's largest collectors of human plasma and is based in Boca Raton, Florida.
Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced new real-world evidence (RWE) supporting the effectiveness of its cell-based and adjuvanted seasonal influenza vaccines. These analyses from a comprehensive set of real-world studies will be presented at the global International Society for Influenza and other Respiratory Virus Diseases (ISIRV)-World Health Organization (WHO) Virtual Conference from October 19-21, 2021.
During its annual R&D investment briefing earlier today, CSL Limited (ASX:CSL; USOTC:CSLLY) highlighted progress from its novel pipeline that spans six therapeutic areas (immunology, hematology, respiratory, cardiovascular and metabolic, transplant, influenza), four scientific platforms (plasma fractionation, recombinant technology, cell and gene therapy, vaccines) and two businesses (CSL Behring and Seqirus).